Health

Results: 5437-5448 of 6042

PR Newswire associated0

Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs

Kexing Biopharm Attended CPHI Worldwide 2023

iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

Diamyd Medical partners with DiaUnion to recruit participants for Type 1 diabetes prevention trial

PR Newswire associated0

QNTM Labs Announces EU-GMP Certified Expansion to Meet Growing Industry Needs

PR Newswire associated0

Registration for the 7th IFPA Conference 2024 now open

Update relating to LEQEMBI® from Eisai's investor presentation of their quarterly report published today

PR Newswire associated0

Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care

Enzymatica AB - Interim report Q3/2023: Research results that reshape the competitive landscape

Essity launches Caressa - a digital platform to assist family caregivers

Calliditas Interim Report January - September 2023

BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate